Cirrosis biliar primaria no típica

Giomara Katherine Ojeda Peláez, Enrique Carrera Estupiñan

Resumen


La Cirrosis Biliar Primaria es una enfermedad crónica del hígado caracterizada por una inflamación

y destrucción progresiva de los conductillos biliares, dando lugar a cuadro de colestasis, que se caracteriza

por elevación de fosfatasa alcalina y GGT con o sin elevación de las transaminasas, afecta

fundamentalmente al sexo femenino.

Se presenta el caso de una mujer de 48 años de edad que ingresa al servicio de gastroenterología por un

cuadro de sangrado digestivo alto de origen variceal que además relata prurito de evolución crónica,

mismo que fue estudiado e incluso realizado biopsia hepática. Se realiza una revisión bibliográfica.


Citas


Medina J, García-Buey L, Moreno-Otero R. Review article: Immunopathogenetic and therapeutic aspects of autoimmune hepatitis. Aliment Pharmacol Ther 2003; 17: 1-16

Sherlock S. Primary biliary cirrhosis (chronic obstructive jaundice). Gastroenterology. 1959;37:574-9. Medline

Christensen E, Crowe J, Doniach D, Popper H, Ranek L, Rodés J, et al. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology. 1980. p. 236-46.

Sherlock S, Scheuer PJ. The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med. 1973; 289:674-8.

Prince M, Chetwynd A, Newman W, Metcalf JV, James OFW. Survival and symptom progression in a geographically based cohort of patients with primary biliary cirrhosis: Follow-up for up to 28 years. Gastroenterology. 2002;1044-51.

Shapiro JM, Smith H, Schaffner F. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut. 1979;20:137-40.

Parés A, Bruguera M, Rodés J. Cirrosis biliar primaria. Evolución clínica y criterios de valor pronóstico. Gastroenterol Hepatol. 1981;4:76-8

Mitchison HC, Bassendine MF, Hendrik A, Bennet MK, Bird G, Watson AJ, et al. Positive antimitochondrial antibody but normal alkaline phosphatase. Is this primary biliary cirrhosis ? Hepatology. 1986;6:1279-84.

Santamaría Ossorio M, Y cols o Romero Blanco P, Molina Pineda de las Infantas I J y Ortega Gromaz C. Ed Con Lab Clín 2004;7:44-52 ENFERMEDADES HEPÁTICAS AUTOINMUNES

Mahl T, Shockcor W, Boyer JL. Primary biliary cirrhosis: survival of a large cohort of symptomatic and asymptomatic patients followed for 24 years. J Hepatol. 1994;20:707-13. Medline

Mitchison HC, Lucey MR, Kelly PJ, Neuberger J, Williams R, James OF. Symptom development and prognosis in primary biliary cirrhosis: a study in two centers. Gastroenterology. 1990;99:778-84. Medline

Beswick DR, Klatskin G, Boyer JL. Asymptomatic primary biliary cirrhosis. A progress report on long-term follow-up and natural history. Gastroenterology. 1985;89:267-71. Medline

Christensen E, Crowe J, Doniach D, Popper H, Ranek L, Rodés J, et al. Clinical pattern and course of disease in primary biliary cirrhosis based on an analysis of 236 patients. Gastroenterology. 1980. p. 236-46.

Parés A, Bruguera M, Rodés J. Cirrosis biliar primaria. Evolución clínica y criterios de valor pronóstico. Gastroenterol Hepatol. 1981;4:76-81.

Roll J, Boyer JL, Barry D, Klatskin G. The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med. 1983;308:1-7. Medline

Shapiro JM, Smith H, Schaffner F. Serum bilirubin: a prognostic factor in primary biliary cirrhosis. Gut. 1979;20:137-40. Medline

Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL et al. Simplified diagnostic criteria for autoimmune hepatitis. Hepatology 2008;48:169-76

Czaja AJ. Treatment of autoimmune hepatitis. Semin Liver Dis 2002; 22: 365-378

Christensen E, Neuberger J, Crowe J, Altman DG, Popper H, Portmann B, et al. Benefitial effect of azathioprine and prediction of prognosis in primary biliary cirrhosis: final results of an international trial. Gastroenterology. 1985;89:1084-91. Medline

Rydning A, Schrumpf E, Abdelnoor M, Elgjo K, Jenssen E. Factors of prognostic importance in primary biliary cirrhosis. Scand J Gastroenterol. 1990;25:119-26. Medline

Gonzalez V, Yantorno M. Conductas en Gastroenterología 2011 tercera edición. Cirrosis biliar primaria.

Scapa, M., & Cano, A. (2007). Cirrosis biliar primaria. Revista Española de Enfermedades Digestivas, 99(6), 358-358

O. Aguilar-Nájera, J.A. Velasco-Zamora, A. Torre- Overlap syndromes of autoimmune hepatitis: diagnosis and treatment. Revista de Gastroenterología de México (English Edition), Volume 80, Issue 2, April–June 2015, Pages 150-159

K.M. Boberg, R.W. Chapman, G.M. Hirschfield, et al. Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol, 54 (2011), pp. 374–385

A.J. Czaja. Diagnosis and management of the overlap syndromes of autoimmune hepatitis. Can J Gastroenterol, 27 (2013), pp. 417–423

Lohse A, Meyer zum Buchenfelde K-H, Franz B, et al. Characterization of the overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 1999;29:1078-84

E.M. Kuiper, P.E. Zondervan, H.R. van Buuren. Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome. Clin Gastroenterol Hepatol, 8 (2010), pp. 530–534

European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. J Hepatol, 51 (2009), pp. 237–267

A. Floreani, I. Franceschet, N. Cazzagon. Primary biliary cirrhosis: Overlaps with other autoimmune disorders. Semin Liver Dis, 34 (2014), pp. 352–360

Metze D, Reimann S, Beissert S, Luger T. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. J Am Acad Dermatol 1999;41:533-539

Bergasa NV, Jones EA. Management of the pruritus of cholestasis: potential role of opiate antagonists. Am J Gastroenterol 1991;86:1404-1412.

Kremer A, Beuers U, Oude-Elferink R, Pusl T. Pathogenesis and treatment of pruritus in colestasis. Drugs 2008;68:2163-82

Maticic M, Poljak M, Lunder T, Rener-Sitar K, et al. Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area. J Eur Acad Dermatol Venereol 2008;22:779-788.

Parés A, Herrera M, Avilés J, Sanz M, Mas A. Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers. J Hepatol 2010;53:307-12

Neuberger J. Transplantation for primary biliary cirrhosis. Semin Liver Dis 1997;17:137-46.

Ann Transplant. 2014 Sep 29;19:488-93. doi: 10.12659/AOT.890753. Primary biliary cirrhosis in the era of liver transplantation.

J Hepatol. 2013 Sep;59(3):490-4. doi: 10.1016/j.jhep.2013.04.017. Epub 2013 Apr 27. The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: a prospective study.


Texto completo: PDF


Creative Commons License
Este trabajo está licenciado bajo la licencia Creative Commons Attribution 3.0 .

logos_latindex_caicyt_400

IntraMed Journal es una publicación de Marketing & Research S.A.
Fray Justo Sarmiento 2350, Olivos 1636 - Buenos Aires, Argentina
0810-222-INTRA (4687) (desde Argentina) 54-11 4136-1880 (desde otros países)
http://journal.intramed.net/ journal@intramed.net
http://www.intramed.net/ info@intramed.net

intramed_logo_2013_100
Términos y condiciones de uso
| Todos los derechos reservados | Copyright 1997-2011 ISSN 1853-6727